BioStock Investor Meeting: Interview with Brain+
CEO Kim Baden-Kristensen presented Danish Brain+ at the BioStock Investor Meeting and afterwards BioStock had a chat with him. Among other things, Baden-Kristensen talked...
BioStock Investor Meeting: Interview with Cereno Scientific
Biotech Cereno Scientific develops new treatments for cardiovascular disease, the most common cause of death worldwide. The company's lead candidate CS1 targets the rare...
Aptahem on the application to initiate clinical studies
Aptahem has submitted applications to the regulatory authorities and to the Central Ethics Committee in the Netherlands for permission to start a phase I...
BioStock Investor Meeting: Lipum presents
Biopharmaceutical company Lipum is developing a new biological drug for the treatment of rheumatoid arthritis (RA) and other chronic inflammatory diseases. The next major...
Erika Samuelsson new CDO at Cyxone
At the beginning of the autumn, First North-listed Cyxone announced the recruitment of Erika Samuelsson as the new Chief Development Officer with responsibility for...
BioStock Investor Meeting: OssDsign presents
Medtech company OssDsign develops and manufactures regenerative implants and patient-specific solutions for the treatment of bone defects. CFO Anders Svensson attended the BioStock Investor...
BioStock Investor Meeting: Arcede Pharma presents
At the end of June this year, following the spin-off from Respiratorius, trading in Arcede Pharma began on Spotlight. At the helm is CEO...
Idogen’s transformation to clinical phase with IDO 8
Recently, the biotech company Idogen received approval from the ethics committee in Oslo for the clinical phase I/IIa study with the cell therapy within...
Green light for Alligator Bioscience and Aptevo Therapeutics
Swedish Alligator Bioscience has developed the bispecific antibody ALG.APV-527 together with American biotech Aptevo Therapeutics. Recently, US authorities have given the project a green...
BioStock Investor Meeting: Expert insights with Mattias Häggblom
BioStock Investor Meeting not only included company presentations but also featured a talk by Mattias Häggblom, Equity Research Analyst and Sector Head Life Science...
